Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril
versus a comparator in the treatment of patients with complicated skin and skin structure
infections.